Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20185012 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)
Condition: Hypercholesterolemia
Interventions: Drug: ezetimibe and atorvastatin;   Drug: atorvastatin;   Drug: Placebo (unspecified)

Indicates status has not been verified in more than two years